跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
REVALOR-XR
Authorized
STANDARD
REVALOR-XR
Intervet Canada Corp
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
dbb2067107d90bde
Company
Intervet Canada Corp
Type
Standard
Approval Details
Approval Id
dbb2067107d90bde
Drug Approval Canada Name
REVALOR-XR
Product Name
REVALOR-XR
Status
Marketed
Status Date
2018-05-09
Original Market Date
2018-05-09
Drug Class
Veterinary
Dosage Form
Implant
Route Of Administration
Subcutaneous
Schedule
NON-PRESCRIPTION DRUGS
Atc Original
Not Applicable
Aig Number
0225804004
Company Name
Intervet Canada Corp
Company Address
16750 Route Transcanadienne Kirkland Quebec Canada H9H 4M7
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
dbb2067107d90bde
Type
Standard
Back to Health Canada Approvals
REVALOR-XR - Health Canada Drug Approval Details